Skin Grafting Anesthesia: Dos and Don'ts
Local infiltrative anesthesia is safe and recommended for skin grafting procedures, with strict adherence to maximum dosing limits to prevent systemic toxicity. 1
DOs for Skin Grafting Anesthesia
Primary Anesthetic Choice
- Use local infiltrative anesthesia as the standard approach for skin grafting procedures 1
- Local anesthesia can be safely combined with topical anesthesia or nerve blocks for larger or more complex grafting procedures 1
Critical Dosing Limits (MUST FOLLOW)
Adults:
- Maximum 4.5 mg/kg lidocaine without epinephrine
- Maximum 7.0 mg/kg lidocaine with epinephrine 1
Children:
- Maximum 1.5-2.0 mg/kg lidocaine without epinephrine
- Maximum 3.0-4.5 mg/kg lidocaine with epinephrine 1
Essential Safety Steps to Prevent Systemic Toxicity (Grade A Evidence)
- Always use the lowest effective dose of local anesthetic
- Aspirate before each injection to avoid intravascular administration
- Use incremental injections rather than bolus dosing
- Continuously monitor and communicate with the patient for early signs of toxicity (perioral numbness, metallic taste, tinnitus, confusion, seizures) 1
Technique Optimization
- Add epinephrine to lidocaine solutions for hemostasis and prolonged anesthetic effect 1
- Buffer the anesthetic with sodium bicarbonate (1 mL of 8.4% per 10 mL lidocaine) to reduce injection pain 2
- Consider hyaluronidase (1500 units mixed with 10 mL lidocaine) for uniform distribution across donor sites, allowing single-pass injection technique 2
- Apply topical EMLA cream preoperatively to donor sites to reduce discomfort 2, 3, 4
Special Populations
- Pregnancy: Lidocaine is FDA Category B and safe in small amounts for local injection 1
- Children: Prioritize topical anesthesia first-line for minimally invasive procedures to reduce anxiety; combine with infiltrative if needed 1
- High-risk patients: Topical anesthesia alone (EMLA) can be used for grafts up to 10% TBSA in elderly or medically compromised patients to avoid general/regional anesthesia risks 3, 5
DON'Ts for Skin Grafting Anesthesia
Absolute Contraindications
- Never exceed maximum dosing limits - this is the most critical pitfall leading to systemic toxicity and potential mortality 1
- Do not use bupivacaine for tumescent anesthesia in skin grafting procedures 1
- Never inject without aspirating first - direct intravascular injection causes immediate toxicity 1
Allergy Management
- Do not assume all "lidocaine allergies" are real - true immunologic reactions occur in only 1% of adverse reactions 1
- If true lidocaine allergy confirmed:
Common Pitfalls to Avoid
- Don't perform large grafts under local anesthesia without calculating total dose - easy to exceed limits when anesthetizing both donor and recipient sites
- Don't rush the injection - rapid infiltration increases pain and patient movement
- Don't forget to monitor glucose control in diabetic patients - topical anesthesia shows better perioperative glucose stability than general/spinal anesthesia 5
Practical Algorithm for Anesthesia Selection
Small grafts (<100 cm²) in cooperative patients:
- Apply EMLA cream to donor site 60 minutes preoperatively
- Infiltrate with buffered lidocaine + epinephrine (calculate dose first)
- Consider hyaluronidase for uniform distribution
Larger grafts or anxious patients:
- Combine topical + infiltrative + nerve block if needed
- Stay within dosing limits by using combination approach
- Consider office-based procedure with field sterility for cost reduction 6
High-risk medical patients:
- Attempt topical anesthesia alone (EMLA) for grafts ≤10% TBSA 3
- Reduces infection risk, hospitalization time, and glucose variability 5
- Avoids general/spinal anesthesia complications
Pediatric patients:
- Start with topical anesthesia to minimize anxiety 1
- Add infiltrative only if topical insufficient
- Use lower pediatric dosing limits strictly
The evidence strongly supports local anesthesia as safe and effective for skin grafting when proper dosing limits and safety protocols are followed. The highest quality evidence (Grade A) emphasizes prevention of systemic toxicity through careful dosing, aspiration, and patient monitoring 1.